teplizumab

Provention Bio

Pharma

FDA signs off on Provention Bio's drug to slow progession of T1D

The FDA approved Provention Bio’s Tzield, the first drug to delay the progression of type 1 diabetes. It will be available to patients 8 and older.

Kevin Dunleavy Nov 18, 2022 10:55am

People shaking hands across a desk that has computer and papers on it

Provention Bio lays commercial groundwork as FDA decision looms

Oct 6, 2022 3:40pm

diabetes strip blood glucose monitor

Provention Bio explores families' diabetes connection in new ads

Oct 22, 2020 9:00am